SEOUL, April 22 (Yonhap) -- Celltrion Inc., a leading South Korean biopharmaceut...
Celltrion to buy back 100 bln won in shares to boost shareholder value
Choi Kyong-ae·Yonhap News··1 min read
Y
Continue reading on Yonhap News
This article was sourced from Yonhap News's RSS feed. Visit the original for the complete story.